Conclusion 15, 304-311 3, 781-790. 1, 836-851 37, 1207-1209 162, 773-779. 24, 659-665 48, 7781-7788. 14, 3275-3278

Proceedings of MatricesFor IITTEP – ICoMaNSEd 2015 ISBN: 978-602-74204-0-3 Chemistry Page 136

4. Conclusion

The conclusion from this paper is several potential inhibitors for endocytosis and dynamin could be developed. Further absorption need to improve thus will trial References Abban, C. Y.; Bradbury, N. A.; Meneses, P. I. HPV16 and BPV1 infection can be blocked by the dynamin inhibitior dynasore. American Journal Therapeutics

2008, 15, 304-311

Aridor, M.; Hannan, L. A. Traffic jams. II: An update of diseases of intracellular transport. Traffic

2002, 3, 781-790.

Aridor, M.; Hannan, L. A. Traffic jam: A compendium of human disease that affect intracelular transport processes. Traffic

2000, 1, 836-851

Bitoun, M.; Maugenre, S.; Jeannet, P. Y.; Lacene, E.; Ferrer, X.; Laforet, P.; Martin, J. L.; Laporte, J.; Locmueller, H.; Beggs, A. H.; Fardeau, M.; Eymard, B.; Romero, N. B.; Guicheney, P. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nature Genetics

2005, 37, 1207-1209

Conner, S. D.; Schmid, S. L. Differential requirements for AP-2 in clathrin-mediated endocytosis. Journal of Cell Biology

2003, 162, 773-779.

Cousin, M. A.; Robinson, P. J. The dephosphins: Dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends in Neurosciences

2001, 24, 659-665

Hill, T. A.; Odell, L. R.; Edwards, J. K.; Graham, M. E.; McGeachie, A. A.; Rusak, J.; Quan, A.; Abagyan, R.; Scott, J. L.; Robinson, P. J.; McCluskey, A. Small molecule inhibitors of dynamin I GTPase activity. Journal of Medicinal Chemistry

2005, 48, 7781-7788.

Hill, T. A.; Odell, L. R.; Quan, A.; Ferguson, G.; Robinson, P. J.; McCluskey, A. Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity. Bioorganic and Medicinal Chemitry Letters

2004, 14, 3275-3278

Liu, J. P.; Robinson, P. J. Dynamin and endocytosis. Endocrine Reviews

1995, 16, 590-607